COVID-19 与神经免疫性疾病的管理。
COVID-19 and management of neuroimmunological disorders.
机构信息
Department of Neurology, Universitätsklinikum Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Center of Neurology and Neuropsychiatry, LVR Klinikum, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
出版信息
Nat Rev Neurol. 2020 Jul;16(7):347-348. doi: 10.1038/s41582-020-0368-9.
Abstract
The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease.
摘要
报道的 2019 冠状病毒病（COVID-19）的神经表现的重要性仍不清楚。然而，COVID-19 大流行带来的一个直接和持续存在的神经学挑战是对正在接受现有神经免疫性疾病免疫治疗的患者进行管理。
相似文献
1
COVID-19 and management of neuroimmunological disorders.COVID-19 与神经免疫性疾病的管理。
Nat Rev Neurol. 2020 Jul;16(7):347-348. doi: 10.1038/s41582-020-0368-9.
2
Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic.神经病学中的远程医疗：SARS-CoV-2疫情管理中不可或缺的工具。
J Neurol. 2020 Jul;267(7):1885-1886. doi: 10.1007/s00415-020-09898-x. Epub 2020 May 12.
3
The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders.2019年冠状病毒病危机成为慢性神经疾病远程医疗的催化剂。
JAMA Neurol. 2020 Aug 1;77(8):927-928. doi: 10.1001/jamaneurol.2020.1452.
4
Neurology and the COVID-19 emergency.神经病学与新型冠状病毒肺炎疫情
Neurol Sci. 2020 Jun;41(6):1343-1344. doi: 10.1007/s10072-020-04465-8.
5
NeuroCOVID: it's time to join forces globally.神经新冠：是时候全球携手合作了。
Lancet Neurol. 2020 Oct;19(10):805-806. doi: 10.1016/S1474-4422(20)30322-7. Epub 2020 Sep 16.
6
Rethinking Regional Neurologic Care in the Coronavirus Disease 2019 Era.对2019冠状病毒病时代区域神经科护理的重新思考
JAMA Neurol. 2020 Sep 1;77(9):1061-1062. doi: 10.1001/jamaneurol.2020.1956.
7
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines.严重急性呼吸综合征冠状病毒2大流行感染中的神经系统疾病谱：神经科医生奔赴前线。
JAMA Neurol. 2020 Jun 1;77(6):679-680. doi: 10.1001/jamaneurol.2020.1065.
8
Health care for chronic neurological patients after COVID-19.新冠疫情后慢性神经疾病患者的医疗保健
Lancet Neurol. 2020 Jul;19(7):562-563. doi: 10.1016/S1474-4422(20)30157-5. Epub 2020 May 25.
9
European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the COVID-19 era.欧洲微创神经治疗学会（ESMINT）关于COVID-19时代最佳介入神经血管管理的建议。
J Neurointerv Surg. 2020 Jun;12(6):542-544. doi: 10.1136/neurintsurg-2020-016137. Epub 2020 Apr 17.
10
Cell-Free Therapies: Novel Approaches for COVID-19.无细胞疗法：治疗新冠肺炎的新方法。
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
引用本文的文献
1
Advanced nanotheranostic approaches for targeted glioblastoma treatment: a synergistic fusion of CRISPR-Cas gene editing, AI-driven tumor profiling, and BBB-modulation.用于靶向胶质母细胞瘤治疗的先进纳米诊疗方法：CRISPR-Cas基因编辑、人工智能驱动的肿瘤分析和血脑屏障调节的协同融合。
Med Oncol. 2025 Aug 7;42(9):413. doi: 10.1007/s12032-025-02944-6.
2
Influencing factors of hypotension during plasma exchange in patients with neuroimmunological diseases: a retrospective cohort study.神经免疫性疾病患者血浆置换期间低血压的影响因素：一项回顾性队列研究
Cardiovasc Diagn Ther. 2025 Apr 30;15(2):414-422. doi: 10.21037/cdt-24-456. Epub 2025 Apr 23.
3
SARS-CoV-2-associated T-cell infiltration in the central nervous system.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）相关的中枢神经系统T细胞浸润
Clin Transl Immunology. 2024 Jan 31;13(2):e1487. doi: 10.1002/cti2.1487. eCollection 2024.
4
Atypical Complications during the Course of COVID-19: A Comprehensive Review.COVID-19 病程中的非典型并发症：全面综述。
Medicina (Kaunas). 2024 Jan 15;60(1):164. doi: 10.3390/medicina60010164.
5
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders.儿童自身免疫性疾病患者的 2019 年冠状病毒病（COVID-19）。
Eur J Pediatr. 2023 Jul;182(7):2967-2988. doi: 10.1007/s00431-023-04958-6. Epub 2023 Apr 19.
6
COVID-19 in children and adolescents with neuroimmunological disorders.患有神经免疫疾病的儿童和青少年中的新冠病毒肺炎
Clinics (Sao Paulo). 2022 Nov 17;78:100142. doi: 10.1016/j.clinsp.2022.100142. eCollection 2023.
7
A Case of Acute Transverse Myelitis in a Mildly Symptomatic Patient: An Emerging and Serious Neurological Manifestation of COVID-19.一名轻症患者的急性横贯性脊髓炎病例：新型冠状病毒肺炎一种新出现的严重神经表现
Cureus. 2022 Apr 17;14(4):e24222. doi: 10.7759/cureus.24222. eCollection 2022 Apr.
8
Global Gene Expression and Docking Profiling of COVID-19 Infection.新冠病毒感染的全基因组表达与对接分析
Front Genet. 2022 Apr 11;13:870836. doi: 10.3389/fgene.2022.870836. eCollection 2022.
9
Vaccination and immunotherapies in neuroimmunological diseases.神经免疫性疾病的疫苗接种和免疫疗法。
Nat Rev Neurol. 2022 May;18(5):289-306. doi: 10.1038/s41582-022-00646-5. Epub 2022 Apr 6.
10
High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity.高水平的细胞外 ATP 根据严重程度导致 COVID-19 患者产生不同的炎症反应。
J Mol Med (Berl). 2022 Apr;100(4):645-663. doi: 10.1007/s00109-022-02185-4. Epub 2022 Mar 6.
本文引用的文献
1
More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.关于严重SARS-CoV-2感染的神经学特征的更多内容。回复。
N Engl J Med. 2020 Jun 25;382(26):e110. doi: 10.1056/NEJMc2015132. Epub 2020 May 26.
2
Characteristics of ischaemic stroke associated with COVID-19.与新型冠状病毒肺炎相关的缺血性卒中的特征
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891. doi: 10.1136/jnnp-2020-323586. Epub 2020 Apr 30.
3
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
4
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome.COVID-19：一种新病毒，但熟悉的受体和细胞因子释放综合征。
Immunity. 2020 May 19;52(5):731-733. doi: 10.1016/j.immuni.2020.04.003. Epub 2020 Apr 22.
5
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic.COVID-19 大流行期间慢性免疫性神经病变的管理挑战。
Muscle Nerve. 2020 Jul;62(1):34-40. doi: 10.1002/mus.26896. Epub 2020 Apr 24.
6
Guillain-Barré Syndrome Associated with SARS-CoV-2.与严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）相关的吉兰-巴雷综合征
N Engl J Med. 2020 Jun 25;382(26):2574-2576. doi: 10.1056/NEJMc2009191. Epub 2020 Apr 17.
7
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
8
Old and new breakthroughs in neuromyelitis optica.视神经脊髓炎的新旧突破
Lancet Neurol. 2020 Apr;19(4):280-281. doi: 10.1016/S1474-4422(20)30062-4. Epub 2020 Mar 18.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.新型冠状病毒（COVID-19）感染中枢神经系统的证据：组织分布、宿主-病毒相互作用及潜在神经嗜性机制。
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
Zotero 插件